Bharat Serums and Vaccines Limited (BSV)

BSV (Bharat Serums and Vaccines Limited) is a leading Indian biopharmaceutical company that is part of Mankind Group and has over 50 years of experience in healthcare. The company’s mission is to preserve, protect and improve people’s quality of life, following the principle “Bringing Life to Life” (“Inspiring life to live”).

BSV specializes in the development, manufacture and promotion of pharmaceutical, biotechnological and biological products, focusing on important therapeutic areas such as:

women’s health (including reproductive problems and infertility),

critical conditions (infections, burns, serious illnesses),

reproductive technologies (IUI-IVF).

The company has a strong global impact: its products are available in more than 70 countries worldwide, and BSV has a number of its own divisions in the USA, Germany and the Philippines. The German manufacturing site was approved by US-FDA and specializes in producing active pharmaceutical ingredients (API) and medicines for women’s health and critical care.

Research and innovation are a key focus of BSV’s activities: the company has its own research and development center in Mumbai with more than 60 scientists working to create new, effective therapeutic solutions for the medical market.

In 2024, BSV was fully acquired by Mankind Pharma, further strengthening its position in the market for biopharmaceutical and reproductive products in India and beyond.